In­cyte’s promis­ing throm­bo­cythemia drug; Cres­cent Bio­phar­ma rais­es $200M in PIPE

Plus, news about D&D Phar­mat­e­ch and Jasper Ther­a­peu­tics:

In­cyte’s throm­bo­cythemia win: The com­pa­ny’s an­ti­body IN­CA033989, which tar­gets and re­duces cells with mu­tant cal­reti­c­ulin (mut­CALR), al­lowed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER